ClinPage recently featured some of the CROs that are dominant in the Brazil market. With over 300 employees in the region and at any given time 150 trials running, PPD, a Wilmington, North Carolina-basd company, dominates the region. They entered Brazil in 1995 when they bought Q&Q Suporte a Pesquisa Clinica, the first established CRO in Brazil. From there, PPD grew organically and spread through other countries in Latin America such as Mexico, Argentina, Chile and Peru.
For more on PPD, read the article here.
Search This Blog
Blog Archive
-
▼
2009
(141)
-
▼
January
(20)
- Drug CROs: Good Medicine for Investors
- Quintiles partners with India’s Apollo Hospitals G...
- Kendle expands in India
- Free Webinar: The Benefits of Establishing a Gover...
- Read the January Partnerships with CROs LinkedIn R...
- Project Management in the Life Sciences: Results f...
- Indigo BioSystems Successfully Tests First Globall...
- Problems in Patient Recruitment in Outsourced Clin...
- ICON annouced as the Clinical Research Company of ...
- Icon increased 2008 earnings
- IRBs are Overloaded with Adverse Events
- South Africa seeing less funding for clinical trials
- FDA Limits Interest in Clinical Trials
- India Expected to Draw More Clinical Trials by 2012
- Insurance and clinical trials
- RNCOS: India Most Economical Destination for Globa...
- Merck and PPD Partner in Outsourcing Deal
- Brazil is critical base for PPD's CROs efforts
- India Offers More Education for Clinical Research
- Ethical Guidelines in India
-
▼
January
(20)
No comments:
Post a Comment